Sarah McWhirter

Sarah McWhirter

Company: Aduro Biotech

Job title: Executive Director, Research and Translational Medicine


Sarah McWhirter serves as Executive Director of Research and Translational Medicine at Aduro Biotech.  Dr. McWhirter has more than 20 years of combined experience in biochemistry, immunology and oncology in both academic and industrial settings. She earned her Ph.D. in Molecular and Cell Biology at University of California, Berkeley in the laboratory of Dr. Tom Alber.  She performed postdoctoral work at Harvard University in the laboratory of Dr. Tom Maniatis studying novel host innate immune signaling pathways.  Over the last several years she has focused her efforts on developing novel therapeutics to treat cancer and autoimmune diseases and currently oversees both the research and early clinical development efforts at Aduro Biotech. 


Live Q&A 12:20 pm

Read more

day: Online Conference

Perspective on STING activators as critical components of combinatorial therapeutic strategies with checkpoint inhibition 11:40 am

• Rationale for STING activation to induce anti-tumor immunity • Highlight examples and define mechanisms by which STING enhances the therapeutic effect of checkpoint inhibition • Overview of clinical approaches utilizing STING agonists in combination with checkpoint inhibitionRead more

day: Online Conference

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.